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Abstract 
BACKGROUND: Eccrine porocarcinoma, first described in 1963, is a rare malignant lesion arising from the eccrine 
sweat glands. It is usually a primary tumor, even more commonly, a malignant degeneration of an eccrine poroma. 
It usually affects elderly, and is located commonly in the lower extremities. About 20% of the cases will reappear 
after treatment. The treatment consists of wide local excision of the primary lesion. This uncommon skin tumor is 
locally aggressive and has a high recurrence rate. 
CASE REPORT: We report a 95-year-old woman with a large tumor on the left knee. A large number of tumoral cells 
showed immunolabeling of p63 supporting squamous or myoepithelial differentiation. They were also positive for 
cytokeratin-7 (CK7), epithelial membrane antigen (EMA), and carcinoembryonic antigen (CEA) highlight luminal 
differentiation in some of the vacuolated cells and this was also seen with periodic acid-Schiff-diastase (PAS-
diastase) staining. 
CONCLUSION: Eccrine porocarcinoma is a rare aggressive form of skin cancer with unknown etiology, and little 
guidance is available in the literature on exact protocols for treatment and follow up. It should be on the differential 
diagnosis of any suspicious skin lesion seen by the plastic surgeon. Histologic assessment is indicated in 
suspicious lesions. 
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Introduction1 
Eccrine porocarcinoma (EPC) is a rare 
malignant cutaneous appendageal tumor that 
develops from intraepidermal eccrine sweat 
duct.1 Pinkus and Mehregan were the first to 
describe EPC in 1963.2 0.005% to 0.01% of all 
epidermal skin neoplasms were caused by 
these tumors.3 Patients’ age ranging is being 
reported from 21 to 90 years old. It occurs 
predominantly in elderly people who are more 
than 60 years, and indicates a female 
predominance. Its etiology is not well 
understood. However, some studies have 
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demonstrated that the tumor developed from a 
pre-existing eccrine poroma.4  
From another point of view, prompting 
factors include chronic light exposure, 
exposure to chemical agents, and 
immunosuppression. Porocarcinoma is a 
hazardous disease because of high rate of 
recurrence after resection and aggressive 
behavior.5 Due to seldom occurrence of the 
problem, there is controversy regarding both 
presentation and management. One 
characteristic histologic feature of EPC is 
ductal differentiation of poromatous basaloid 
epithelial cells that forms an irregular tumor 
shap.6 Prevalent occurring sites consist of 
lower extremities, followed by the trunk, head, 
and upper and lower limbs.7 
Case Report 
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Case Report 
She was a 95-year-old woman with a large 
tumor on the left knee. The sections of biopsy 
in year 2014 showed skin and underlying 
tissues containing a highly infiltrative adnexal 
carcinoma. The tumor composed 
predominantly of nests of epithelial cell, with 
round nuclei, and vacuolated cytoplasm lying 
myxoid stroma. Some cells had cytoplasmic 
vacuoles. Many of the nests showed central 
zone necrosis. Many mitotic figures were 
presented. Areas of squamous differentiation 
were also accompanied by focal differentiation 
to form ductal lumina. These areas mostly 
consisted of porocarcinoma cells. In some areas 
of the tumor, there was abundant myxoid 
stroma; that was less expected in 
porocarcinoma, and suggested chondroid 
syrindoma. The neoplasm had high infiltrative 
growth pattern, extending to all of the margins 
of the biopsy (Figure 1).  
 
 
Figure 1. Hematoxylin and eosin (H&E) staining 
(× 100) showing high infiltrating growth pattern 
with margin involvement 
 
There was also pagetoid invasion of 
overlying epidermis. Most of the tumoral cells 
showed immunolabeling for p63 supporting 
squamous or myoepithelial differentiation 
(Figure 2).  
 
Figure 2. P63 staining (× 400) strongly 
supporting squamous differentiation 
 
Most of the cells were also positive for 
cytokeratin-7 (CK7), epithelial membrane antigen 
(EMA), and carcinoembryonic antigen (CEA) 
highlight luminal differentiation (Figure 3). 
 
 
Figure 3. Immunohistochemistry (IHC) staining  
(× 400) of carcinoembryonic antigen (CEA) 
supporting luminal differentiation 
 
A few number of the vacuolated cells were 
also seen via periodic acid-Schiff-diastase 
(PAS-diastase) staining (Figure 4).  
There was a few amount of 
intracytoplasmic mucins indicated in some of 
the cells. Sections of excision in year 2017 
showed a recurrence of the tumor that had the 
identical morphology to the one seen in year 
2014. Extensive areas of necrosis were seen. 
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The recurrent tumor appeared to have been 
excised incompletely again. 
 
 
Figure 4. Mucin staining (× 400) highlighting 
luminal differentiation 
Discussion 
Theoretically, EPC develops from benign to 
malignant. EPC is a biologically aggressive 
neoplasm and has a high rate of recurrence 
and metastasis.8 Its histogenesis is yet to be 
known, but is believed to have an origin from 
the acrosyringium.9,10 From the view of 
histology, EPC has two types: intraepidermal, 
and dermal porocarcinoma. The 
intraepidermal type develops horizontally and 
generates pagetoid infiltration along the 
epidermis; the dermal form indicates nodular 
aggregates, usually without attachment to the 
epidermis.11  
Our patient had an intraepidermal lesion 
presented with mitotic figures, such as affected 
dermis. The EPC clinical manifestations are not 
specific, and different types of papule, nodule, 
and plaque form lesions with various sizes (1-
10 cm) could be seen.12-14 According to 
Mulinari-Brenner et al. review article, the 
lesions can be sized between 1.2 × 2.0 and 4 × 5 
cm.15 EPC is more common in women and has 
had higher incidence in the age group of 70 
years in some case studies.15,16  
Bowen’s disease, extramammary Paget’s 
disease, cutaneous metastasis, amelanotic 
melanoma, cutaneous lymphoma, cutaneous 
squamous cell carcinoma, and other primary 
skin appendageal tumors should be in mind as 
differential diagnosis.16 Robson et al. in a case 
series of 69 patients with EPC concluded that 
aggressive behavior might be the exception;  
as they reported 17, 10, and 20 percent that 
local recurrence, distant metastasis, and lymph 
node metastasis in EPC cases, respectively.17  
This issue is confirmed by some other 
researchers.8-10,18  
It should be noticed that despite these case 
series, diagnosis, treatment, and prognosis 
issues of EPC are still provocative due to the 
lack of enough data on this disease. Some 
authors recommended the four 
histopathological findings as predictive factors 
in patients with EPC;17-19 as lymphovascular 
invasion, and invasion depth of more than 7 
mm or more than 14 mitoses per 10 high-
power field (HPF) was associated with death, 
and infiltrative growth pattern was prognostic 
of local recurrence.17,19 
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